Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 163

1.

Malignant pleural mesothelioma: role of CT, MRI, and PET/CT in staging evaluation and treatment considerations.

Truong MT, Viswanathan C, Godoy MB, Carter BW, Marom EM.

Semin Roentgenol. 2013 Oct;48(4):323-34. doi: 10.1053/j.ro.2013.03.017. Review. No abstract available.

PMID:
24034264
2.

Use of computed tomography and positron emission tomography/computed tomography for staging of local extent in patients with malignant pleural mesothelioma.

Frauenfelder T, Kestenholz P, Hunziker R, Nguyen TD, Fries M, Veit-Haibach P, Husmann L, Stahel R, Weder W, Opitz I.

J Comput Assist Tomogr. 2015 Mar-Apr;39(2):160-5. doi: 10.1097/RCT.0000000000000174.

PMID:
25354093
3.

What is the best way to diagnose and stage malignant pleural mesothelioma?

Zahid I, Sharif S, Routledge T, Scarci M.

Interact Cardiovasc Thorac Surg. 2011 Feb;12(2):254-9. doi: 10.1510/icvts.2010.255893. Epub 2010 Nov 1. Review.

PMID:
21044972
4.

Bilateral thoracoscopy, mediastinoscopy and laparoscopy, in addition to CT, MRI and PET imaging, are essential to correctly stage and treat patients with mesothelioma prior to trimodality therapy.

Alvarez JM, Hasani A, Segal A, Sterret G, Millward M, Nowak A, Musk W, Bydder S.

ANZ J Surg. 2009 Oct;79(10):734-8. doi: 10.1111/j.1445-2197.2009.05060.x.

PMID:
19878170
5.

New applications of magnetic resonance imaging for thoracic oncology.

Ohno Y.

Semin Respir Crit Care Med. 2014 Feb;35(1):27-40. doi: 10.1055/s-0033-1363449. Epub 2014 Jan 30. Review.

PMID:
24481757
6.

Imaging in pleural mesothelioma: a review of the 11th International Conference of the International Mesothelioma Interest Group.

Armato SG 3rd, Labby ZE, Coolen J, Klabatsa A, Feigen M, Persigehl T, Gill RR.

Lung Cancer. 2013 Nov;82(2):190-6. doi: 10.1016/j.lungcan.2013.08.005. Epub 2013 Aug 15. Review.

PMID:
24018024
7.

Discrepancies and priorities in staging and restaging malignant lymphoma by SPET, SPET/CT, PET/CT and PET/MRI.

Chavdarova LI, Tzonevska AD, Piperkova EN.

Hell J Nucl Med. 2013 Sep-Dec;16(3):223-9. doi: 10.1967/s002449910098. Epub 2013 Oct 2. Review.

PMID:
24137584
8.

Computed tomography, positron emission tomography, positron emission tomography/computed tomography, and magnetic resonance imaging for staging of limited pleural mesothelioma: initial results.

Plathow C, Staab A, Schmaehl A, Aschoff P, Zuna I, Pfannenberg C, Peter SH, Eschmann S, Klopp M.

Invest Radiol. 2008 Oct;43(10):737-44. doi: 10.1097/RLI.0b013e3181817b3d.

PMID:
18791416
9.

Multimodality imaging for characterization, classification, and staging of malignant pleural mesothelioma.

Nickell LT Jr, Lichtenberger JP 3rd, Khorashadi L, Abbott GF, Carter BW.

Radiographics. 2014 Oct;34(6):1692-706. doi: 10.1148/rg.346130089. Review.

PMID:
25310424
10.

Response evaluation in mesothelioma: Beyond RECIST.

Cheng L, Tunariu N, Collins DJ, Blackledge MD, Riddell AM, Leach MO, Popat S, Koh DM.

Lung Cancer. 2015 Dec;90(3):433-41. doi: 10.1016/j.lungcan.2015.08.012. Epub 2015 Aug 22. Review.

PMID:
26443279
11.

PET/CT versus MRI for diagnosis, staging, and follow-up of lung cancer.

Kim HS, Lee KS, Ohno Y, van Beek EJ, Biederer J.

J Magn Reson Imaging. 2015 Aug;42(2):247-60. doi: 10.1002/jmri.24776. Epub 2014 Nov 4. Review.

PMID:
25365936
12.

Morphologic and functional imaging of malignant pleural mesothelioma.

Yamamuro M, Gerbaudo VH, Gill RR, Jacobson FL, Sugarbaker DJ, Hatabu H.

Eur J Radiol. 2007 Dec;64(3):356-66. Epub 2007 Oct 22. Review.

PMID:
17954021
13.

Preoperative evaluation of patients with malignant pleural mesothelioma: role of integrated CT-PET imaging.

Truong MT, Marom EM, Erasmus JJ.

J Thorac Imaging. 2006 May;21(2):146-53. Review.

PMID:
16770231
14.

Malignant pleural mesothelioma: evaluation with CT, MR imaging, and PET.

Wang ZJ, Reddy GP, Gotway MB, Higgins CB, Jablons DM, Ramaswamy M, Hawkins RA, Webb WR.

Radiographics. 2004 Jan-Feb;24(1):105-19. Review.

PMID:
14730040
15.

Imaging of multiple myeloma: usefulness of MRI and PET/CT.

Koppula B, Kaptuch J, Hanrahan CJ.

Semin Ultrasound CT MR. 2013 Dec;34(6):566-77. doi: 10.1053/j.sult.2013.05.006. Review.

PMID:
24332208
16.

Diagnostic accuracy of sequential co-registered PET+MR in comparison to PET/CT in local thoracic staging of malignant pleural mesothelioma.

Martini K, Meier A, Opitz I, Weder W, Veit-Haibach P, Stahel RA, Frauenfelder T.

Lung Cancer. 2016 Apr;94:40-5. doi: 10.1016/j.lungcan.2016.01.017. Epub 2016 Jan 28.

PMID:
26973205
17.

High-resolution whole-body magnetic resonance image tumor staging with the use of parallel imaging versus dual-modality positron emission tomography-computed tomography: experience on a 32-channel system.

Schmidt GP, Baur-Melnyk A, Herzog P, Schmid R, Tiling R, Schmidt M, Reiser MF, Schoenberg SO.

Invest Radiol. 2005 Dec;40(12):743-53.

PMID:
16304476
18.

Imaging of mesothelioma.

Gill RR.

Recent Results Cancer Res. 2011;189:27-43. doi: 10.1007/978-3-642-10862-4_3. Review.

PMID:
21479894
19.

Malignant pleural mesothelioma: initial experience in integrated (18)F-FDG PET/MR imaging.

Schaarschmidt BM, Sawicki LM, Gomez B, Grueneisen J, Hoiczyk M, Heusch P, Buchbender C.

Clin Imaging. 2016 Sep-Oct;40(5):956-60. doi: 10.1016/j.clinimag.2016.05.001. Epub 2016 May 11.

PMID:
27232931
20.

Therapy response evaluation in malignant pleural mesothelioma with integrated PET-CT imaging.

Steinert HC, Santos Dellea MM, Burger C, Stahel R.

Lung Cancer. 2005 Jul;49 Suppl 1:S33-5. Epub 2005 Apr 11. No abstract available.

PMID:
15950798

Supplemental Content

Support Center